PuSH - Publikationsserver des Helmholtz Zentrums München

Dragano, N.R.V. ; Milbank, E.* ; Haddad-Tóvolli, R.* ; Garrido-Gil, P.* ; Novoa, E.* ; Fondevilla, M.F.* ; Capelli, V.* ; Zanesco, A.M.* ; Solon, C.* ; Morari, J.* ; Pires, L.* ; Estevez-Salguero, A.* ; Beiroa, D.* ; González-García, I.* ; Barca-Mayo, O.* ; Diéguez, C.* ; Nogueiras, R.* ; Labandeira-García, J.L.* ; Rexen Ulven, E.* ; Ulven, T.* ; Claret, M.* ; Velloso, L.A.* ; López, M.*

Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance.

Mol. Metab. 79:101840 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
OBJECTIVE: Free fatty acid receptor-1 (FFAR1) is a medium- and long-chain fatty acid sensing G protein-coupled receptor that is highly expressed in the hypothalamus. Here, we investigated the central role of FFAR1 on energy balance. METHODS: Central FFAR1 agonism and virogenic knockdown were performed in mice. Energy balance studies, infrared thermographic analysis of brown adipose tissue (BAT) and molecular analysis of the hypothalamus, BAT, white adipose tissue (WAT) and liver were carried out. RESULTS: Pharmacological stimulation of FFAR1, using central administration of its agonist TUG-905 in diet-induced obese mice, decreases body weight and is associated with increased energy expenditure, BAT thermogenesis and browning of subcutaneous WAT (sWAT), as well as reduced AMP-activated protein kinase (AMPK) levels, reduced inflammation, and decreased endoplasmic reticulum (ER) stress in the hypothalamus. As FFAR1 is expressed in distinct hypothalamic neuronal subpopulations, we used an AAV vector expressing a shRNA to specifically knockdown Ffar1 in proopiomelanocortin (POMC) neurons of the arcuate nucleus of the hypothalamus (ARC) of obese mice. Our data showed that knockdown of Ffar1 in POMC neurons promoted hyperphagia and body weight gain. In parallel, these mice developed hepatic insulin resistance and steatosis. CONCLUSIONS: FFAR1 emerges as a new hypothalamic nutrient sensor regulating whole body energy balance. Moreover, pharmacological activation of FFAR1 could provide a therapeutic advance in the management of obesity and its associated metabolic disorders.
Impact Factor
Scopus SNIP
Altmetric
7.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Ffar1/gpr40 ; Fatty Acids ; Food Intake ; Hypothalamus ; Obesity ; Pomc ; Thermogenesis
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2212-8778
e-ISSN 2212-8778
Zeitschrift Molecular Metabolism
Quellenangaben Band: 79, Heft: , Seiten: , Artikelnummer: 101840 Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam
Begutachtungsstatus Peer reviewed
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500692-001
PubMed ID 38036170
Erfassungsdatum 2025-01-09